Lotus Pharmaceuticals, Inc., a developer, manufacturer and seller of medicine and drugs in China, has appointed Jeff Hon as its new chief financial officer.
Hon, who will oversee Lotus’s finance, investments and internal investor relations, will report directly to Dr. Liu. Prior to joining Lotus, Hon was the manager of the IPO/M&A department in the Hong Kong office of Westcomb Financial Group Ltd., an investment banking firm based in Singapore.
Previously, he was the senior consultant at Sunbelt Business Advisors, a U.S. M&A consulting firm based in Hong Kong. Prior to that, he served as corporate development manager of Shanghai Technology Company Ltd., a wholly-owned subsidiary of Shanghai Broadband Technology Company Ltd., a Chinese company listed on the Shanghai Stock Exchange.
Hon received his Bachelor of Electronic Engineering (Honors) degree from the City University of Hong Kong, a Master’s degree in Corporate Finance from the Polytechnic University of Hong Kong, and a Master’s degree in Professional Accounting from Southern Cross University of Australia.